diabetic retinopathy
Conditions
Interventions
Group A:No intravitreal injection of conbercept during pars plana vitrectomy
Group B:intravitreal injection of conbercept during pars plana vitrectomy
Sponsors
Tongji Hospital of Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years, and the gender is not limited; 2. Activity PDR, with vitreous bleeding and/or retina fiber vascular membrane; 3. All patients are detailed in eye examinations that meet serious PDR; 4. Signing the consent of informed consent and agreed to use the information for clinical research.
Exclusion criteria
Exclusion criteria: 1. Combined with eye diseases that affect vision, such as RVO, AMD, etc.; 2. History of PPV surgery; 3. Intravitreal injection or retina photocoagulation within 6 months before surgery; 4. NVG; 5. severe eye infection; 6. Use anticoagulation or antiplatelet drugs; 7. Poor diabetes before or after surgery; 8. There are serious systemic diseases; 9. Pregnant women; 10. Allergy to Conbercept; 11. The postoperative follow-up time is less than 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence of early and late vitreous hemorrhage; | — |
Secondary
| Measure | Time frame |
|---|---|
| best corrected visual acuity;intraocular pressure;macular fovea thickness; | — |
Countries
China
Contacts
Public ContactHoushuo Li
Tongji Hospital of Tongji University
Outcome results
None listed